Abstract
Objective
In Norway, very little data are available on the relation between the total number of research projects on the clinical development of drugs that have been started, the number of these projects in which the research phase has been completed and the number of projects for which results have been published. The aim of this study was to determine the number of projects in which the research phase had been completed and the results published.
Material and methods
Information on research projects carried out on the clinical development of drugs during the year 2000 was obtained from the archives of the Norwegian Research Ethical Committee (REC) and subsequently analysed.
Results
The final analysis revealed that 245 research projects on the clinical development of drugs had been started in 2000. Of these, 178 (73%) completed the research phase as planned. The results of 131 (54%) of these projects were published in a scientific journal, and another 34 (14%) were reported as a congress abstract or as report to a sponsor; 80 (33%) were not published at all. Industrial sponsors seemed to promote both the completion of the research process and the publication of results in scientific journals.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hole OP, Winther FO, Straume B (2001) Clinical research: the influence of the pharmaceutical industry. Eur J Clin Pharmacol 56:851–853
Winther FO, Hole OP, Nitter-Hauge S (2007) An analysis of the clinical developement of drugs in Norway for the years 2000 and 2004: the influence of the pharmaceutical industry. Eur J Clin Pharmacol 63:909–912
World Medical Association Declaration of Helsinki (2004). Ethical principles for medical research involving human subjects. Adopted June 1964; ammended at the 55th WMA General Assembly, Tokyo
Sandaker L, Fjeld B, Reikvam AA et al (2004) Klinisk legemiddelutprøving I Norge – gjennomføring og rapportering er ikke tilfredstillende. Tidsskr Nor Laegeforen 124:2888–2889
Winther FO, Hole OP (1997) Scientific quality of clinical research: an analysis of 40 research projects in pharmacology/pharmacotherapy. Eur J Clin Pharmacol 51:351–354
Salisbury MW (2008) Best biotech places and emerging clusters, Genome Technology June 2008, pp 35-39. Available at: http://www.genome-technology.com/issues/2_15/coverstory/1472
Acknowledgements
This work was supported by The National Committee for Medical and Health Research Ethics and University of Oslo, Medical Faculty, Division Rikshospitalet.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hole, O.P., Nitter-Hauge, S., Cederkvist, H.R. et al. An analysis of the clinical development of drugs in Norway for the year 2000: the completion of research and publication of results. Eur J Clin Pharmacol 65, 315–318 (2009). https://doi.org/10.1007/s00228-008-0601-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-008-0601-8